433 related articles for article (PubMed ID: 18852694)
1. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
4. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
[TBL] [Abstract][Full Text] [Related]
5. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
9. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARα levels.
Chang CJ; Tzeng TF; Liou SS; Chang YS; Liu IM
Planta Med; 2011 Nov; 77(17):1876-82. PubMed ID: 21728151
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins.
Yashiro T; Nanmoku M; Shimizu M; Inoue J; Sato R
Atherosclerosis; 2012 Feb; 220(2):369-74. PubMed ID: 22153697
[TBL] [Abstract][Full Text] [Related]
11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.
Jeong S; Kim M; Han M; Lee H; Ahn J; Kim M; Song YH; Shin C; Nam KH; Kim TW; Oh GT; Yoon M
Metabolism; 2004 May; 53(5):607-13. PubMed ID: 15131765
[TBL] [Abstract][Full Text] [Related]
13. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
[TBL] [Abstract][Full Text] [Related]
14. HVC1 ameliorates hyperlipidemia and inflammation in LDLR
Cheon SY; Chung KS; Lee KJ; Choi HY; Ham IH; Jung DH; Cha YY; An HJ
BMC Complement Altern Med; 2017 Apr; 17(1):222. PubMed ID: 28427397
[TBL] [Abstract][Full Text] [Related]
15. Hypolipidemic effect of fenugreek seeds is mediated through inhibition of fat accumulation and upregulation of LDL receptor.
Vijayakumar MV; Pandey V; Mishra GC; Bhat MK
Obesity (Silver Spring); 2010 Apr; 18(4):667-74. PubMed ID: 19851306
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
[TBL] [Abstract][Full Text] [Related]
17. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Hepatology; 2008 Sep; 48(3):770-81. PubMed ID: 18752326
[TBL] [Abstract][Full Text] [Related]
19. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α.
Tateno C; Yamamoto T; Utoh R; Yamasaki C; Ishida Y; Myoken Y; Oofusa K; Okada M; Tsutsui N; Yoshizato K
Toxicol Pathol; 2015 Feb; 43(2):233-48. PubMed ID: 25107573
[TBL] [Abstract][Full Text] [Related]
20. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
